EUVIMEDEUVIMED entdecken
Crossref

Efficacy of metformin on different adipocytokines in type 2 diabetes mellitus patients

Naglaa Hamdy, Mohamed Abdel-Gabbar, Hader I. Sakr, Mohamed A. Abdelaziz, Mohamed Kandeil, Ayman M. Abdel Aziz, Osama M. Ahmed

Egyptian Pharmaceutical Journal · 2024-04 · 23 (2) · 207-215

DOI: 10.4103/epj.epj_150_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Pharmaceutical Journal, online erschienen am 25.04.2024. Verfasst von Naglaa Hamdy und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus is a major medical condition that constitutes a significant financial burden on most healthcare systems.

Objective

The current research aimed to evaluate the antidiabetic, anti-inflammatory, and antihyperlipidemic effects of 500 mg metformin twice daily for 6 months on various adipocytokines in type 2 diabetes mellitus patients. Patients and methods The participants in this study were divided into three groups: the control, the untreated diabetic, and the metformin-treated diabetic groups. Results and conclusion Metformin treatment significantly improved the poor oral glucose tolerance and the lowered serum levels of insulin and C-peptide with subsequent better homeostatic model assessment for insulin resistance and sensitivity and β-cell function results. Moreover, metformin treatment significantly decreased the elevated serum levels of glycosylated hemoglobin, high, low, and very low-density lipoproteins, adipokines (visfatin and resistin), and retinol-binding protein-4 expression, with a significant increase in total cholesterol and triglycerides. Metformin also reduced the proinflammatory cytokine expressions (interleukin-1β, interferon-γ, and tumor-necrosis factor-α). In conclusion, metformin can alleviate adipocytokines through anti-inflammatory effects, synergizing with its antidiabetic actions.

Zitieren

APA

Hamdy, N., Abdel-Gabbar, M., Sakr, H. I., Abdelaziz, M. A., Kandeil, M., Aziz, A. M. A., & Ahmed, O. M. (2024). Efficacy of metformin on different adipocytokines in type 2 diabetes mellitus patients. Egyptian Pharmaceutical Journal, 23(2), 207-215. https://doi.org/10.4103/epj.epj_150_23

Vancouver

Hamdy N, Abdel-Gabbar M, Sakr HI, Abdelaziz MA, Kandeil M, Aziz AMA, et al. Efficacy of metformin on different adipocytokines in type 2 diabetes mellitus patients. Egyptian Pharmaceutical Journal. 2024;23(2):207-215. doi:10.4103/epj.epj_150_23

BibTeX
@article{Hamdy2024,
  author = {Hamdy, Naglaa and Abdel-Gabbar, Mohamed and Sakr, Hader I. and Abdelaziz, Mohamed A. and Kandeil, Mohamed and Aziz, Ayman M. Abdel and Ahmed, Osama M.},
  title = {Efficacy of metformin on different adipocytokines in type 2 diabetes mellitus patients},
  journal = {Egyptian Pharmaceutical Journal},
  year = {2024},
  volume = {23},
  number = {2},
  pages = {207--215},
  doi = {10.4103/epj.epj_150_23}
}
Kostenlos starten →